HLA-G class I gene expression in normal and malignant hematopoietic cells

被引:72
作者
Amiot, L [1 ]
Onno, M [1 ]
Drénou, B [1 ]
Monvoisin, C [1 ]
Fauchet, R [1 ]
机构
[1] Univ Rennes 1, Lab Hematol & Biol Cellules Sanguines, Fac Med, F-35043 Rennes, France
关键词
D O I
10.1016/S0198-8859(98)00041-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The class Ib HLA-G gene encodes for a molecule which is selectively expressed in fetal placental cells. Fetomaternal tolerance could be partially explained by the interactions between HLA-G molecules and KIR receptors of decidual NK cells. To determine whether the presence of HLA-G antigens might constitute a factor of immune tolerance during the tumoral process, we compared the expression of the HLA-G gene in normal and malignant hematopoietic cells. Despite a HLA-G transcriptional activity in several lymphocytes and monocytes, no antigens are found at the cell surface or in the cytosol using the specific HLA-G mAb, 87G. This lack of expression does not appear modified in malignant hematopoietic cells. However, treatment of the monohistiocytic cell line U937 with different cytokines enabled the expression of HLA-G antigens to be induced. We suggest that the potential induction of HLA-G molecules in monocytic malignant cells following secretion of cytokines may constitute a factor of immune tolerance in patients. Human Immunology 59, 524-528 (1998). (C) American Society for Histocompatibility and Immunogenetics, 1998. Published by Elsevier Science Inc.
引用
收藏
页码:524 / 528
页数:5
相关论文
共 11 条
[1]   Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia [J].
Amiot, L ;
Onno, M ;
Drenou, B ;
leMarchand, B ;
Lamy, T ;
Semana, G ;
Fauchet, R .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1996, 23 (04) :311-320
[2]   HLA-G transcription studies during the different stages of normal and malignant hematopoiesis (vol 47, pg 408, 1996). [J].
Amiot, L ;
Onno, M ;
Renard, I ;
Drenou, B ;
Guillaudeux, T ;
LeBouteiller, P ;
Fauchet, R .
TISSUE ANTIGENS, 1996, 48 (05) :608-614
[3]  
FUJII T, 1994, J IMMUNOL, V153, P5516
[4]   ALTERNATIVE SPLICING OF HLA-G TRANSCRIPTS YIELDS PROTEINS WITH PRIMARY STRUCTURES RESEMBLING BOTH CLASS-I AND CLASS-II ANTIGENS [J].
ISHITANI, A ;
GERAGHTY, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3947-3951
[5]   AN ALTERNATIVELY SPLICED FORM OF HLA-G MESSENGER-RNA IN HUMAN TROPHOBLASTS AND EVIDENCE FOR THE PRESENCE OF HLA-G TRANSCRIPT IN ADULT LYMPHOCYTES [J].
KIRSZENBAUM, M ;
MOREAU, P ;
GLUCKMAN, E ;
DAUSSET, J ;
CAROSELLA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4209-4213
[6]   A CLASS-I ANTIGEN, HLA-G, EXPRESSED IN HUMAN TROPHOBLASTS [J].
KOVATS, S ;
MAIN, EK ;
LIBRACH, C ;
STUBBLEBINE, M ;
FISHER, SJ ;
DEMARS, R .
SCIENCE, 1990, 248 (4952) :220-223
[7]   THE MEMBRANE-BOUND AND SOLUBLE FORMS OF HLA-G BIND IDENTICAL SETS OF ENDOGENOUS PEPTIDES BUT DIFFER WITH RESPECT TO TAP ASSOCIATION [J].
LEE, N ;
MALACKO, AR ;
ISHITANI, A ;
CHEN, MC ;
BAJORATH, J ;
MARQUARDT, H ;
GERAGHTY, DE .
IMMUNITY, 1995, 3 (05) :591-600
[8]   Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells [J].
Munz, C ;
Holmes, N ;
King, A ;
Loke, YW ;
Colonna, M ;
Schild, H ;
Rammensee, HG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :385-391
[9]   THE HLA-G GENE IS EXPRESSED AT A LOW MESSENGER-RNA LEVEL IN DIFFERENT HUMAN-CELLS AND TISSUES [J].
ONNO, M ;
GUILLAUDEUX, T ;
AMIOT, L ;
RENARD, I ;
DRENOU, B ;
HIREL, B ;
GIRR, M ;
SEMANA, G ;
LEBOUTEILLER, P ;
FAUCHET, R .
HUMAN IMMUNOLOGY, 1994, 41 (01) :79-86
[10]  
Soderstrom K, 1997, J IMMUNOL, V159, P1072